Risk of Hypertension Linked to HIV Drug: Study
In 2019, the World Health Organization formally recommended the drug dolutegravir (DTG) as the preferred antiretroviral therapy (ART) for people
Risk of Hypertension Linked to HIV Drug: Study
In 2019, the World Health Organization formally recommended the drug dolutegravir (DTG) as the preferred antiretroviral therapy (ART) for people